Dichotomous parvalbumin interneuron populations in dorsolateral and dorsomedial striatum by Monteiro, Patrícia Isabel Rodrigues et al.
1 
 
Dichotomous parvalbumin interneuron populations in dorsolateral and 
dorsomedial striatum 
Patricia Monteiro 1,2,3,4, Boaz Barak1, Yang Zhou1, Rebecca McRae1, Diana Rodrigues4, Ian 
R. Wickersham1 and Guoping Feng1,2 
 
Conflict of Interest: the authors declare no competing financial interests. 
 
Author contribution:  
Patricia Monteiro: Conception or design of the work; Acquisition or analysis or interpretation of data for the work; 
Drafting the work or revising it critically for important intellectual content; Final approval of the version to be 
published; Agreement to be accountable for all aspects of the work; Boaz Barak: Acquisition or analysis or 
interpretation of data for the work; Final approval of the version to be published; Agreement to be accountable for 
all aspects of the work; Yang Zhou: Acquisition or analysis or interpretation of data for the work; Final approval 
of the version to be published; Agreement to be accountable for all aspects of the work; Rebecca McRae: 
Acquisition or analysis or interpretation of data for the work; Final approval of the version to be published; 
Agreement to be accountable for all aspects of the work; Ian R. Wickersham: Acquisition or analysis or 
interpretation of data for the work; Final approval of the version to be published; Agreement to be accountable for 
all aspects of the work; Guoping Feng: Conception or design of the work; Acquisition or analysis or interpretation 
of data for the work; Drafting the work or revising it critically for important intellectual content; Final approval of 
the version to be published; Agreement to be accountable for all aspects of the work. 
Funding: 
This work was funded by the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard 
and a doctoral fellowship from the Portuguese Foundation for Science and Technology to P.M. 
(SFRH/BD/33894/2009). Research in the Laboratory of Guoping Feng has been supported by the Poitras Center 
for Affective Disorders Research at MIT, Stanley Center for Psychiatric Research at Broad Institute of MIT and 
Harvard, National Institute of Health (NINDS and NIMH), Alfred P. Sloan Foundation, American Heart 
Association, The Arnold and Mabel Beckman Foundation, The EJLB Foundation, The Esther A. & Joseph 
Klingenstein Fund, The Hartwell Foundation, March of Dimes Birth Defects Foundation, McKnight Endowment 
Fund for Neuroscience, Nancy Lurie Marks Family Foundation, Ruth K. Broad Foundation for Biomedical 
Research, Simons Foundation Autism Research Initiative (SFARI), and The Whitehall Foundation. B.B. was 
supported by postdoctoral fellowships from the Simons Center for the Social Brain at MIT and the Autism Science 
Foundation and is currently a faculty at The School of Psychological Sciences and Sagol School of Neuroscience, 
Tel Aviv University, Israel. P.M. is currently supported by Society in Science, The Branco Weiss Fellowship, 
administered by Eidgenössische Technische Hochschule (ETH) Zürich, and European Molecular Biology 
Organization (EMBO) Long-Term Fellowship (ALTF 89–2016).  
Acknowledgements:  
We thank Triana Dalia, Sarah Schneck and Heather Sullivan for technical support and all Feng lab members for 
helpful discussion, especially Holly Robertson, Qiangge Zhang and Dongqing Wang. P.M would like to thank 
Prof. Nuno Sousa and Fernanda Marques (ICVS, UMinho, Portugal), Prof. Carlos Duarte (UCoimbra, Portugal), 
and to acknowledge the support from ‘‘Programa Doutoral em Biologia Experimental e Biomedicina’’ (CNC, 
Coimbra, Portugal).   
                                                          
1 McGovern Institute for Brain Research, Department of Brain and Cognitive Sciences; Massachusetts Institute of 
Technology; Cambridge, MA, 02139; USA 
2 Stanley Center for Psychiatric Research; Broad Institute of MIT and Harvard; Cambridge, MA, 02139; USA 
3  PhD Programme in Experimental Biology and Biomedicine (PDBEB), Center for Neuroscience and Cell 
Biology; University of Coimbra; Coimbra, 3004; Portugal 
4 Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho and ICVS/3B’s - 
PT Government Associate Laboratory, Braga/Guimarães, 4710–057; Portugal 
 
2 
 
 
Dichotomous parvalbumin interneuron populations in dorsolateral and 
dorsomedial striatum 
Patricia Monteiro 1,2,3,4, Boaz Barak1, Yang Zhou1, Rebecca McRae1, Diana Rodrigues4, Ian 
R. Wickersham1 and Guoping Feng1,2 
 
Running title: Parvalbumin interneurons in dorsal striatum 
 
 
Corresponding author - Name:  Guoping Feng 
Corresponding author - Address:  
McGovern Institute for Brain Research 
Department of Brain and Cognitive Sciences 
Massachusetts Institute of Technology 
MIT, 46-3143A 
43 Vassar Street 
Cambridge, MA  02139 
Corresponding author - Phone:  617-715-4898; 617-715-4920 
Corresponding author - Fax: 617 324-6752 
Corresponding author - E-mail address:  fengg@mit.edu 
  
    
Keywords: Parvalbumin, Fast spiking interneurons, Striatum  
 
 
Key points summary:  
 
 Existence of two electrophysiological dichotomous populations of parvalbumin (PV) 
interneurons located in the dorsal striatum. 
 
 Striatal PV interneurons in medial and lateral regions significantly differ in their 
intrinsic excitability.  
 
 Parvalbumin interneurons in dorsomedial striatum, but not dorsolateral striatum, 
receive afferent glutamatergic input from cingulate cortex.   
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Dichotomous parvalbumin interneuron populations in dorsolateral and 
dorsomedial striatum 
 
 
ABSTRACT 
 
Dorsomedial striatum circuitry is involved in goal-directed actions or movements that upon 
repetition become habits, encoded by dorsolateral striatum. An inability to shift from habits can 
compromise action-control and prevent behavioral adaptation. But although these regions seem 
to be clearly behaviorally distinct, little is known about their distinct physiology. 
 Parvalbumin (PV) interneurons are a major source of striatal inhibition and are usually 
considered as a homogeneous population in the entire dorsal striatum. Here, we recorded PV 
interneurons in dorsal striatum slices from WT male mice and suggest the existence of two 
electrophysiological dichotomous populations. We found that PV interneurons located at the 
dorsomedial striatum region have increased intrinsic excitability as compared to PV 
interneurons in dorsolateral region. We also found that PV interneurons in dorsomedial region, 
but not dorsolateral striatum region, receive short-latency excitatory inputs from cingulate 
cortex. Therefore, our results demonstrate the importance of considering region specific 
parvalbumin interneuron populations when studying dorsal striatal function.  
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INTRODUCTION 
 
Daily goal-directed actions often become habitual automated responses after 
consecutive repetition (Yin and Knowlton, 2004; Yin et al., 2004, 2005, 2006; Hilário and 
Costa, 2008; Baldan Ramsey et al., 2011; Hilario et al., 2012). Striatum function is crucial for 
this habit-formation and for proper psychomotor behavior such as motor control, procedural 
learning and behavioral switching (Yin and Knowlton, 2006; Hilário and Costa, 2008; Steiner 
and Tseng, 2010; Parent, 2012). Adult striatum dysfunction results in loss of action-control 
(Graybiel, 2008) and its dysfunction has recently been linked to OCD and ASD (Ahmari et al., 
2013; Burguière et al., 2014; Monteiro and Feng, 2015, 2017; Ahmari, 2016), thickening the 
list of previously known classic striatum-related disorders such as Parkinson and Huntington’s 
disease (Kreitzer and Malenka, 2008; Plotkin and Surmeier, 2015). 
Parvalbumin (PV) interneurons are critical circuit modulators and are thought to be 
malleable throughout life in the adult brain (Plotkin et al., 2005; Kepecs and Fishell, 2014; 
Dehorter et al., 2015). In rodent striatum, PV interneurons represent only a small neuronal 
percentage (~1%) but provide prominent feedforward inhibition to medium-spiny projection 
neurons (MSNs) (Tepper et al., 2008; Gittis et al., 2010). Decreased numbers of striatal PV 
interneurons, but not MSNs, have been reported in post-mortem caudate and putamen tissue 
from patients with Tourette syndrome, suggesting a link between action-control and interneuron 
pathology in specific striatum sub-regions (Kataoka et al., 2010; Xu et al., 2015, 2016).  In 
rodents, DMS and DLS regions are part of an homogeneous structure, lacking the anatomical 
segregation between caudate and putamen regions seen in primates (Reep et al., 2003; Voorn 
et al., 2004). However, PV expression, is more abundant laterally than medially in rodents (Kita 
et al., 1990; Todtenkopf et al., 2004). Given this anatomical segregation of PV expression, we 
asked whether striatum PV interneurons could be electrophysiologically different in DLS 
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versus DMS regions. Our data provides the first evidence of dichotomous physiological 
properties between PV interneurons located in the two striatum regions. 
 
MATERIALS AND METHODS 
Ethical Approval 
All animal procedures were reviewed and approved by the MIT Committee on Animal Care 
(CAC). Only male mice were used for experiments. Detailed methods are described below. 
 
Experimental animals 
PV-Cre mice (Pvalbtm1(cre)Arbr) were purchased from the Jackson Laboratory (JAX Stock 
No:008069) and ROSA26-stopflox-tdTomato cKI mice were gently provided by Dr. Fan Wang 
(Duke University School of Medicine). Both mouse lines have been previously described 
(Hippenmeyer et al., 2005; Arenkiel et al., 2011). Specific primers were designed in this study 
to distinguish PV-cre heterozygous from homozygous mice: 
Primer 5'-GCTCAGAGCCTCCATTCCCT-3' 
Primer 5'-GCTCAGAGCCTCCATTCCCT-3' 
Primer 5'-CAGCCTCTGTTCCACATACACTTC-3' 
ROSA26-stopflox-tdTomato+/+ mice were crossed with PV-Cre mice to generate PV-Cre+/-
:ROSA26-stopflox-tdTomato+/+ mice for electrophysiology recordings. Animals were housed 
on controlled environment (12h light/dark cycles, 24h temperature and humidity monitoring), 
2-5 mice per cage and ad libitum food and water. All experimental procedures were reviewed 
and approved by the MIT Committee on Animal Care (CAC). 
 
Slice preparation 
Acute striatal slices were prepared from 6-8-week-old PV-cre+/-:ROSA26-stopflox-
tdTomato+/+. Animals were anesthetized by avertin intraperitoneal injection (tribromoethanol, 
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20 mg/ml, 0.5 mg/g body weight) and transcardially perfused with cutting NMDG-based aCSF 
(mM): 92 N-methyl-D-glucamine (NMDG), 2.5 KCl, 1.20 NaH2PO4, 30 NaHCO3, 20 HEPES, 
25 glucose, 2 thiourea, 5 Na-ascorbate, 3 Na-pyruvate, 0.5 CaCl2.2H2O, 10 MgSO4.7H2O 
(~300 mOsm, 7.2-7.4 pH) (Ting et al., 2014). Following decapitation, brain was removed and 
coronal brain slices (300 µm) were prepared using a Vibratome 1000 Plus (Leica Microsystems, 
USA). Slices were recovered in cutting solution at 32–34°C for 10-15 minutes and transferred 
to room-temperature carbogenated regular aCSF (mM): 119 NaCl, 2.5 KCl, 1.2 NaH2PO4, 24 
NaHCO3, 12.5 glucose, 2 MgSO4.7H2O, 2 CaCl2.2H2O (~300 mOsm, 7.2-7.4 pH). All slices 
were allowed to recover at least ≥1h prior to whole-cell recordings. 
 
Electrophysiology recordings 
Slices were transferred to the recording chamber (RC-27L, Warner Instruments) and constantly 
perfused with carbogenated regular aCSF at 30±2°C, ~2 ml/minute rate. Borosilicate glass 
microelectrodes (King Precision Glass) were pulled on a P-97 horizontal puller (Sutter 
Instruments) and backfilled either with KGlu, CsCl or CsGlu internal (KGlu mM: 145 K-
Gluconate, 10 HEPES, 1 EGTA, 2 MgATP, 0.3 NaGTP and 2 MgCl2; pH adjusted to 7.3 with 
KOH and osmolarity adjusted to ~300 mOsm with sucrose. CsGlu mM: 110 CsOH, 110 D-
Gluconic acid, 15 KCl, 4 NaCl, 5 TEA-Cl, 20 HEPES, 0.2 EGTA, 5 Lidocaine N-ethyl chloride, 
4 MgATP, 0.3 NaGTP; pH adjusted to 7.3 with KOH and osmolarity adjusted to ~300 mOsm 
with K2SO4. CsCl mM: 103 CsCl, 12 CsOH, 12 Methanesulfonic acid, 5 TEA-Cl, 10 HEPES, 
0.5 EGTA, 5 Lidocaine N-ethyl chloride, 4 MgATP, 0.3 NaGTP, 10 Phosphocreatine, 4 NaCl; 
pH adjusted to 7.3 with KOH and osmolarity adjusted to ~300 mOsm with K2SO4), presenting 
a typical resistance around 2-4 MΩ.  
Slices were visualized under IR-DIC (infrared-differential interference contrast) using a BX-
51WI microscope (Olympus) and recordings were obtained after seal rupture and internal 
equilibrium from visually identified tdTomato-positive cells. All recordings were always 
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obtained in parallel for both cell populations (DLS-PV and DMS-PV) along the lateral-medial 
striatal axis within each brain slice. Only the DLS region close to the corpus callosum and DMS 
close to the lateral ventricles, were targeted for recordings to avoid any potential “intermediate” 
region. Input resistance was obtained through extrapolation from the I-V plot as well as direct 
measurement through -150pA hyperpolarizing current step. 
Picrotoxin 100 uM and TTX 1 uM were added for mEPSC experiments and AP-V 50 uM, 
NBQX 10 uM and TTX 1 uM were added for mIPSC experiments (all drugs from Tocris). 
Striatal EPSCs and EPSPs were evoked by a 0.1ms stimulation step (Isoflex, AMPI) delivered 
at 0.05Hz frequency by a platinum iridium concentric bipolar electrode (CBAPC75, FHC) 
placed in cingulate cortex layers 4/5 (stimulation electrode 1-1.5mm away; stimulation intensity 
ranged from 0.1 to 3.0mA). Latency was measured as the time between the stimulation 
(electrode artifact) and the onset of the resulting EPSC. EPSPs and action potential (AP) 
graphically displayed traces were obtained at −50 mV by gradual increasing stimulation 
intensity until AP firing. Stimulation artifacts were partly removed for clarity of the EPSP 
figure. Summary EPSP data (onset time, peak, rise and decay time) were extracted from the 
largest evoked EPSP at −70 mV from pairs of PV-MSN adjacently located (same stimulation 
electrode location and intensity for each PV-MSN pair). Analysis of EPSCs and EPSPs was 
performed on averaged responses from 3-5 sweeps. PV cells were identified based on tdTomato 
signal and all presented hyperpolarized resting membrane potential (~ -85mV) and typical AP-
shape upon current-injection. Putative MSNs were identified based on soma size (12-20 µm), 
absence of tdTomato signal, typical hyperpolarized resting membrane potential (~ -85mV) and 
typical AP-shape upon current-injection. EPSP rise time was measured from 10% to 90% of 
the peak amplitude of the synaptic response. Decay time was measured by a single exponential 
fit. Onset of Cg-evoked DMS-EPSPs was measured as the delay between the stimulus delivery 
and the EPSP foot. Data was acquired using a MultiClamp 700B amplifier and a Digidata 
1440A. Signals were filtered at 1-2 KHz and digitized at 10 KHz. For current-clamp recordings, 
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bridge balance was adjusted and pipette capacitance neutralized. Series resistance 
compensation (<20 MΩ) was performed in voltage-clamping mode. Theoretical liquid junction 
potential was estimated to be around −11 mV and not corrected-for. 
 
Antibodies 
Mouse and rabbit anti-parvalbumin antibodies (PV235 and PV27, 1:5000 dilution) from Swant; 
mouse anti-DARPP32 (611520, 1:1000) from BD Biosciences; rabbit anti-Somatostatin 
(AB5494, 1:200) from Milllipore; rabbit anti-Neuropeptide Y (T-4070, 1:250) from Peninsula 
Laboratories International; goat anti-ChAT antibody (AB144P, 1:500 dilution) from Millipore; 
chicken anti-GFP (ab13970, 1:5000) from Abcam. 
 
Morphological experiments and quantification of PV immunoreactivity 
For morphological experiments Biocytin (0.3-0.5% w/v) was included in KGlu internal solution 
during patch clamp recordings. Recorded slices were fixed in 4 % PFA (paraformaldehyde), 
kept in 4 % PFA overnight at 4 °C, and then transferred to PBS. Next day slices were incubated 
for 2h in AlexaFluor-488 streptavidin conjugate (1:1000, Invitrogen), washed 3x in PBS and 
mounted for imaging. For TSA-immunohistochemistry, rabbit anti-parvalbumin antibody 
(Swant, PV27) was used together with Tyramide signal amplification (TSA) (Invitrogen, T-
20922) according to TSA kit instructions. Quantification of PV-immunoreactivity was 
performed using cellSens imaging software (Olympus). 
 
IHC and microscope imaging 
Mice were anesthetized by isoflurane inhalation and transcardially perfused with PBS solution 
followed by 4 % PFA (paraformaldehyde) fixative solution. Brains were kept in 4 % PFA 
overnight at 4 °C, then transferred to PBS and sectioned at 50 microns. Sections were washed 
3x in PBS and permeabilized for 5 minutes using a PBS solution containing 10% MeOH, 3% 
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H2O2, and 0.5% NaBH2, except for ChAT immunostaining and virus experiments. Slices were 
again washed 3x PBS and incubated in 1.2 % Triton-X 100 for 15 minutes, followed by another 
3x PBS wash. Blocking was then performed for 1h in PBS containing 2% BSA and 0.2% Triton-
X. Primary antibodies were incubated overnight at 4°C for detection of the respective antigens. 
Next day sections were washed 3x PBS, followed by 2-4h incubation with secondary antibody 
(species-specific Alexa-conjugated antibody, 1:1500, Invitrogen) at room temperature. Lastly, 
sections were washed 3x PBS, stained for DAPI, mounted in ProlongGold (Invitrogen) or 
Fluoro-Gel (Electron Microscopy Sciences) and imaged using Olympus Fluoview FV1000 
confocal and Olympus BX61 microscopes. Serial sections were reconstructed as 3D models 
using BioVis3D software (http://www.biovis3d.com/, Montevideo, Uruguay). 
 
Surgeries and viruses 
6-8 weeks old mice were anesthetized with isoflurane, placed on a stereotactic frame and viral 
injections performed using a Nanoject device (Drummond scientific). For monosynaptic tracing 
experiments we injected ~0.2 µl of undiluted AAV2/8-synP-DIO-sT-P2A-EGFP-P2A-B19G 
(2.29e12 gc/ml [gc = genome copies]) at DLS or DMS (bregma coordinates for guide cannula 
implantation: DLS ML+2.75, AP+0.5, 2.0; DMS ML+2.0, AP+0.5, 2.3; please note that the 
injector/infusion cannula further extends 1mm DV). 2-3 weeks later we injected ~0.2µl of 
undiluted RV-ΔG-RFP(EnvA) (titer 2.75E9 i.u./ml [i.u. = infectious units]) at the same bregma 
location. All stereotaxic coordinates are from bregma/skull. Mice were sacrificed 7days later to 
observe expression pattern. AAV-synP-DIO-sTpEpG and RVΔG-RFP(EnvA) were generated 
by I.R.W. from MIT Genetic Neuroengineering Group  (Massachusetts Institute of Technology) 
(Kohara et al., 2014). 
 
Experimental Design and Statistical Analysis  
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All statistical analyses were performed using Prism (GraphPad Software) and MATLAB 
Software (MathWorks). Non-normal distributions were assumed for all the datasets regardless 
of variance and sample size. Pairwise comparisons were performed using Mann Whitney test 
for unpaired data and Wilcoxon Signed Rank test for paired data comparisons, with a threshold 
of p<0.05 for significance. All datasets are presented as means ± s.e.m. Further details on 
particular analyses can also be found on the respective figures/results section and Table 1. 
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RESULTS  
To study dorsal striatum PV interneurons, we started by crossing PV-Cre mice with 
ROSA26-stopflox-tdTomato reporter mice, to fluorescently label PV interneurons for cell-
targeted patch clamp recordings. Immunostaining of PV-Cre:tdTomato+ striatal brain sections, 
showed faithful colocalization between tdTomato signal and PV immunostaining, indicating 
successful tdTomato expression under the control of endogenous PV promoter (Fig. 1). To 
further confirm correct PV interneurons labeling by this strategy, we also performed separate 
immunostaining protocols with other well-known striatal markers. Colocalization was not 
observed between tdTomato native signal and immunostaining for other striatal markers such 
as DARPP32, SOM, NPY, or ChAT, indicating a correct reporting strategy (Fig. 1). 
We next examined passive and active membrane properties by performing whole-cell 
intracellular electrophysiology. Recordings from PV interneurons located in DMS and DLS 
regions showed that these populations markedly differed in intrinsic excitability (Fig. 2A-E and 
Table1). PV located in DMS showed higher intrinsic excitability, as represented by their 
leftshifted I-V curve (Fig. 2A). Input resistance obtained through extrapolation from the I-V 
plot as well as direct measurement through a -150 pA hyperpolarizing current step, showed 
significantly higher values for DMS-PV than DLS-PV (Fig. 2B) (DMS-PV mean= 43 MΩ; 
DLS-PV mean= 28 MΩ). In addition, significantly higher membrane resistance was observed 
for the DMS population (Fig. 2B) (DMS-PV mean= 118 MΩ; DLS-PV mean= 85 MΩ). Active 
membrane properties also showed that DMS-PV interneurons are more excitable, displaying a 
left-shifted I-F curve (Fig. 2C). Action potential triggering (rheobase) also required less current 
injection compared to DLS-PV population (DMS-PV mean= 424 pA; DLS-PV mean= 584 pA) 
(Fig. 2D). Resting membrane potential (DMS-PV= -86 mV; DLS-PV= -85 mV) and spike 
threshold (DMS-PV mean= -39 mV; DLS-PV mean= -41 mV; Fig. 2E) were not different 
between the two populations, and thus do not seem to contribute for the observed excitability 
differences. 
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But because differences in excitability can also arise from differences in membrane 
surface area, we measured whole-cell capacitance (roughly proportional to membrane surface 
area). Capacitance recordings confirmed smaller values for DMS-PV than DLS-PV (Fig. 2F), 
suggesting that the differences in excitability could be attributable, at least in part, to different 
membrane areas.  
To explore if these differences in electrophysiology could accompany differences in 
morphology, we acquired morphological data from DMS-PV and DLS-PV by using TSA-
enhanced parvalbumin immunostaining (Fig. 3) and by using biocytin-filled patch pipettes 
during electrophysiology recordings. We found that DLS-PV consistently displayed more 
extensive arborization and complexity than DMS-PV interneurons. This morphological 
observation supports whole-cell capacitance measurements, which indicated larger capacitance 
values for DLS-PV than DMS-PV. Quantification of PV-immunoreactivity also showed 
stronger detection in the more lateral regions of the striatum compared to DMS (Fig.3).  
We next investigated striatal synaptic connectivity for both PV populations. 
Significantly higher mEPSC frequency was observed in DMS-PV interneurons as compared to 
DLS-PV interneurons, with no significant differences in amplitude (Fig. 2G and Table1). In 
addition, DMS-PV received significantly fewer inhibitory synapses than DLS-PV, with no 
differences in amplitude (Fig. 2H and Table1). These results could suggest the existence of two 
discrete PV populations with functional differences in synaptic connectivity. Given that local 
synapses within the striatum are inhibitory, the mEPSC frequency data suggested that either 
DMS-PV received more excitatory inputs from a shared afferent source with DLS-PV, or that 
DMS-PV received inputs from an afferent source distinct from DLS-PV. 
To resolve this question at the cellular level, we decided to generate modified 
pseudotyped rabies-virus and performed for the first time in vivo Cre-dependent monosynaptic 
retrograde tracing specifically from striatal PV interneurons. 
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 First, a conditional helper virus (AAV-synP-DIO-sTpEpG) was injected either into 
DMS or DLS region of PV-Cre mice. After Cre-mediated recombination, this AAV helper virus 
expressed EGFP and two proteins: TVA (receptor for the avian EnvA, necessary for subsequent 
rabies virus infection) and B19G (the rabies glycoprotein necessary for monosynaptic 
retrograde spreading) (Wall et al., 2010). Then, two weeks post injection, modified EnvA-ΔG-
RFP-rabies-virus (EnvA-pseudotyped, G-deleted, RFP-rabies) was injected into the same 
location, allowing monosynaptic retrograde tracing from striatum PV interneurons (Fig. 4A). 
Histological analysis revealed that DMS-PV interneurons receive dense afferent 
innervation from cingulate cortex (Cg) (Movie 1 and Fig. 4B,C,F, Fig. 5A-C). This cortical 
projection was not observed for PV interneurons in DLS region (Movie 2 and Fig. 4D,E,G). 
Both populations of PV interneurons in DMS and DLS seemed to integrate histological inputs 
from thalamus and GP regions. 
To functionally test this identified  cortical-DMS-PV projection, we placed a stimulation 
electrode in deep-layer Cg and recorded post-synaptic evoked responses from DMS region. 
Given that PV interneurons in DLS do not received inputs from Cg, we compared DMS PV 
interneurons with neighboring MSN-tdTomato negative neurons. 
Stimulation of cingulate cortex evoked a reliable glutamatergic excitatory response in 
both DMS-MSN neurons and DMS-PV interneurons (Fig. 5D-E and Table1). The average 
latency of cortical-evoked DMS-EPSCs was significantly shorter in PV interneurons than 
DMS-MSNs, indicating a rapid cortical recruitment of striatal inhibition (Fig. 5D-E and 
Table1). Cortical-evoked subthreshold DMS-EPSPs had a trend for faster onset time and trend 
for larger amplitude in DMS-PV interneurons compared to neighboring DMS-MSNs (Fig. 5F-
G and Table1). Rise time was not significantly different between MSN and PV interneurons, 
although DMS-EPSPs decay time had a trend for slower in MSNs (Fig. 5H-I and Table1). These 
observations indicated that DMS-PV interneurons are strongly enervated by cingulate cortex 
and cortical inputs may affect PV interneurons more strongly than MSN neurons, potentially 
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allowing PV interneurons to control the recruitment and spread of second messengers more 
efficiently in the striatum. Moreover, these findings demonstrate for the first time that, similar 
to medium-spiny neurons, PV interneurons also receive glutamatergic inputs from distinct 
cortical regions along the medial-lateral axis of the striatum.  
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DISCUSSION 
Our findings demonstrate the existence of two dichotomous PV interneuron populations 
along the medial-lateral axis of the dorsal striatum. Whole-cell recordings revealed that DMS-
PV interneurons have more excitable intrinsic membrane properties as compared to PV 
interneurons in dorsolateral region. Given the important role of the DMS region during initial 
behavioral learning (Yin et al., 2005; Ragozzino, 2007), having a more excitable PV population 
in this region could provide means for efficient behavioral inhibition during an initial ‘trial-
and-error’ learning phase. In a scenario where an unexpected outcome occurs and behavioral 
flexibility is required (e.g. early learning phase), a more excitable PV population, such as the 
DMS-PV population, could therefore be more easily triggered and inhibit/shape local MSNs 
firing to promote behavioral adaptation. On the other hand, once a task has been extensively 
repeated and a specific behavioral strategy has proven to be effective, it should be preserved 
and not easily changed (habitual behavior; DLS-mediated). In this second habitual scenario, 
stronger inputs would thus be needed to activate the less excitable DLS-PV interneurons and 
stop an ongoing habitual response.  
Moreover, the fact that associative Cg inputs specifically target DMS-PV interneurons, 
but not PV interneurons in dorsolateral striatum, further suggests that these discrete PV 
populations in lateral and medial territories are part of distinct corticostriatal networks and may 
in fact contribute to the hypothesized parallel/competing roles of DLS and DMS in controlling 
behavior (Hilario et al., 2012). Our data provide the first evidence of dichotomous physiological 
properties between PV interneurons along the medial-lateral axis of the dorsal striatum, and 
highlight the importance of considering region specific parvalbumin interneuron populations 
when studying the dorsal striatum. 
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FIGURES 
 
Figure 1. Native tdTomato expression shows faithful colocalization with PV staining in 
striatal sections from PV-cre:tdTomato mice. 
Pvalbtm1(cre)Arbr: ROSA26-stopflox-tdTomato mice express tdTomato fluorescence in striatal 
parvalbumin interneurons. Fluorescence images of histological sections show colocalization of 
native tdTomato expression (red) with endogenous PV immunoreactivity, but not DARPP32, 
SOM, NPY or ChAT. 
 
Figure 2. DMS-PV interneurons have distinct intrinsic excitability and synaptic 
physiology from DLS-PV interneurons. 
Higher intrinsic excitability for DMS-PV is shown by their left-shifted IV curve (A) and higher 
input and membrane resistance (B). (C) IF-plot with representative current injection steps 
demonstrates increased excitability for DMS-PV interneurons compared to DLS-PV. Please 
note that the graph only displays current injections up to 740 pA but many DLS-PV required 
much higher current injections for firing. Given that above 740 pA, many DMS-PV entered in 
“depolarization blockade” and become inexcitable, the graph is only displayed up to that value. 
 (D) Lower rheobase current values indicate higher excitability of DMS-PV compared to DLS-
PV. (E) No difference in firing threshold. (F) DMS-PV interneurons have smaller capacitance 
(p<0.001, two-sample Kolmogrov-Smirnov test). (G) Summary bar graphs and cumulative 
probability curves (200 events per interneuron) show significantly increased mEPSC frequency 
in DMS-PV, with no difference in amplitude. (H) Summary bar graphs and cumulative 
probability curves (140 events per interneuron) show that DMS-PV interneurons have reduced 
mIPSC frequency; with no difference in amplitude. Example traces are shown at the bottom for 
G,H. *p<0.05; **p<0.01; ***p<0.001; All statistical analyses are in Table 1. 
 
Figure 3. DLS-PV interneurons have more abundant parvalbumin expression and display 
more complex morphology than DMS-PV. 
(A) Parvalbumin interneurons display significantly higher PV intensity per cell in dorsolateral 
striatum compared to dorsomedial striatum (***p< 0.001; n=80 DLS-PV cells and n=80 DMS-
PV cells; two-way ANOVA for the left cumulative frequency curves and Kolmogorov–
Smirnov test for right histogram distribution). (B) Reconstructed morphology of PV 
interneurons in DLS (top) and DMS (bottom), after TSA-enhanced parvalbumin 
immunostaining. 
 
Figure 4. Cre-dependent monosynaptic retrograde tracing from striatum parvalbumin 
interneurons. 
 (A) Adult PV-Cre mice are injected in the DLS or DMS with AAV expressing TVA, EGFP 
and rabies glycoprotein (AAV-DIO-sTpEpG) in a Cre-dependent manner. Two weeks later, the 
same mice are injected with EnvA-pseudotyped monosynaptic rabies that can only infect PV 
interneurons expressing TVA, and can only retrogradely spread from PV interneurons 
expressing rabies glycoprotein (G). One week after rabies injection, direct inputs onto striatal 
PV interneurons become labeled (RFP). (B, C, F) DMS-PV interneurons receive dense inputs 
from cingulate cortex (Cg). RFP labelled Cg-axons can be observed in coronal section. (D, E, 
G) DLS-PV interneurons receive inputs from motor (M1, M2), somatosensory cortex and from 
other PV within DLS, but not cingulate cortex (Cg). LO - lateral orbital cortex, FrA - frontal 
association cortex, PrL - prelimbic cortex, Cg1 - cingulate cortex, area 1, Cg2 - cingulate cortex, 
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area 2, M1 - primary motor cortex, M2 - secondary motor cortex, S1 - primary somatosensory 
cortex, S2 - secondary somatosensory cortex, RSC - retrosplenial cortex. 
 
Figure 5. DMS-PV interneurons receive afferent glutamatergic input from Cingulate 
cortex (Cg). 
 (A) Cg projection neurons (RFP+) revealed by Cre-dependent retrograde monosynaptic 
labeling from DMS-PV infected interneurons (GFP+). (B) Zoomed image from square area 
depicted in A; Cg axons (red) projecting to DMS-PV interneurons (green) can be seen in detail. 
(C) White arrows show DMS-PV interneurons co-infected by AAV-sTpEpG (green) and RV-
ΔG-RFP(EnvA) (red); Blue arrow shows a DMS-PV interneuron expressing only RFP, due to 
rabies retrograde labeling from other synaptically connected PV interneurons. (D, E) Brain slice 
cartoon and representative traces showing that stimulation of Cg reliably evokes post-synaptic 
excitatory responses (NBQX-sensitive EPSC) in DMS-PV interneurons and neighboring 
MSNs; Cumulative distribution of EPSC latency after Cg stimulation shows significantly 
shorter latencies for DMS-PV interneurons compared to MSNs. (F-I) Summary data extracted 
from the largest evoked subthreshold EPSP in each pair of PV-interneuron and its respective 
neighboring-MSN. Representative subthreshold EPSP traces are represented on the left side for 
both cell types. Each trace results from a gradual increase in the stimulation intensity until 
action-potential triggering (insets show the full action-potential trace). Statistical analyses are 
in Table 1. 
 
Movie 1. Cre-dependent monosynaptic retrograde tracing from parvalbumin 
interneurons in DMS. 
3D model reconstructed from serial sections showing afferent cells that project onto 
dorsomedial striatal PV interneurons. 
 
Movie 2. Cre-dependent monosynaptic retrograde tracing from parvalbumin 
interneurons in DLS. 
3D model reconstructed from serial sections showing afferent cells that project onto 
dorsolateral striatal PV interneurons. 
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Table 1. Experimental Design and Statistical Analysis 
          
Figure Measurement N  Mean±s.e.m. 
Statistical test and P 
value 
Fig.2B (top) Input resistance (MΩ) DMS-PV=25 cells 42.76± 2.01 
Mann Whitney test, 
***p<0.0001 
    DLS-PV=25 cells 28.21 ± 1.255   
Fig.2B 
(bottom) 
Membrane  resistance 
(MΩ) 
DMS-PV=25 cells 118.1 0± 8.68 
Mann Whitney test, 
**p=0.0013 
    DLS-PV=25 cells 84.70 ± 7.44   
Fig. 2D Rheobase current (pA) DMS-PV=25 cells 424.4 ± 26.05 
Mann Whitney test, 
**p=0.0019 
    DLS-PV=25 cells 583.6 ± 36.17   
Fig. 2E Firing threshold (mV) DMS-PV=15 cells -39.40± 1.17 
Mann Whitney test, 
p=0.1624 
    DLS-PV=15 cells -41.20 ± 1.34   
Fig. 2G mEPSC Frequency (Hz) DMS-PV=12 cells 22.31± 1.78 
Mann Whitney test, 
*p=0.0229 
    DLS-PV=10 cells 15.49± 1.26   
  mEPSC Amplitude (pA)   15.25 ± 0.83 
Mann Whitney test, 
p=0.1062 
      13.08 ± 0.80   
Fig. 2H mIPSC Frequency (Hz) DMS-PV=16 cells 5.68 ± 0.49 
Mann Whitney test, 
**p=0.0098 
    DLS-PV=16 cells 8.17± 0.79   
  mIPSC Amplitude (pA)   29.66± 2.01 
Mann Whitney test, 
p=0.1011 
      24.42 ± 1.43   
Fig. 5D, 5E EPSC Latency (ms) DMS-PV=8 cells 5.49± 0.44 
Wilcoxon Signed 
Rank test, *p=0.0156 
    DMS-MSN=8 cells 7.04 ± 0.73   
Fig. 5F EPSP Onset time (ms) DMS-PV=5 cells 5.42± 0.71 
Wilcoxon Signed 
Rank test, p=0.1250 
    DMS-MSN=5 cells 6.88 ± 1.32   
Fig. 5G EPSP Peak (mV) DMS-PV=5 cells 7.73± 1.96 
Wilcoxon Signed 
Rank test, p=0.4375 
    DMS-MSN=5 cells 6.31 ± 1.43   
Fig. 5H EPSP Rise time (ms) DMS-PV=5 cells 3.58± 0.41 
Wilcoxon Signed 
Rank test, p=1.0000 
    DMS-MSN=5 cells 3.67 ± 0.52   
Fig. 5I EPSP Decay time (ms) DMS-PV=5 cells 19.22± 1.64 
Wilcoxon Signed 
Rank test, p=0.0625 
    DMS-MSN=5 cells 27.45± 1.43   
 
 





